“We don’t have the same bodies; we don’t react the same way”: mothers and adolescent girls’ perceptions of the risks and benefits of HPV vaccination in France

References

• European Centre for Disease Prevention and Control. Guidance for the introduction of HPV vaccines in EU countries. Sweden, Stockholm: ECDC; 2008.
   Google Scholar
• De Figueiredo A, Karafillakis E, and Larson H. State of Vaccine Confidence in the EU+ UK. Belgium, Brussels: European Commission; 2020.
   Google Scholar
• Chaturvedi AK. Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Health;. 2010;46(4):S20–9. doi:10.1016/j.jadohealth.2010.01.016.
   PubMed Web of Science ®Google Scholar
• Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX, and de Sanjosé Salmaso S. Human Papillomavirus and related diseases in the world. Spain, Catalonia: ICO Information Centre on HPV and Cancer; 2016.
   Google Scholar
• Clifford G, Franceschi S, Diaz M, Munoz N, Villa LL. HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine. 2006;24:26–34. doi:10.1016/j.vaccine.2006.05.026.
   Web of Science ®Google Scholar
• Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer. 2003;88(1):63–73. doi:10.1038/sj.bjc.6600688.
   PubMed Web of Science ®Google Scholar
• Levy-Bruhl D, Bousquet V, King LA, O’Flanagan D, Bacci S, Lopalco PL, Salmaso S, Keepe CSVG. The current state of introduction of HPV vaccination into national immunisation schedules in Europe: results of the VENICE 2008 survey. Eur J Cancer. 2009;45(15):2709–13. doi:10.1016/j.ejca.2009.07.023.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Introduction of HPV vaccines in European Union countries - an update. Sweden, Stockholm: ECDC; 2012.
   Google Scholar
• Bonanni P, Faivre P, Lopalco PL, Joura EA, Bergroth T, Varga S, Gemayel N, Drury R. The status of human papillomavirus vaccination recommendation, funding, and coverage in WHO Europe countries (2018–2019). Expert Rev Vaccines. 2020;19(11):1073–83. doi:10.1080/14760584.2020.1858057.
   PubMed Web of Science ®Google Scholar
• Santé Publique France. Cancer du col de l’utérus. France, Paris: Santé Publique France; 2021. https://www.santepubliquefrance.fr/maladies-et-traumatismes/cancers/cancer-du-col-de-l-uterus Accessed 07 February 2022.
   Google Scholar
• Haut Conseil de la Santé Publique. Vaccination contre les infections à papillomavirus humains. France, Paris: Haut conseil de la santé publique; 2014.
   Google Scholar
• Ward JK, Crépin L, Bauquier C, Vergelys C, Bocquier A, Verger P, Peretti-Watel P. ‘I don’t know if I’m making the right decision’: French mothers and HPV vaccination in a context of controversy. Health Risk Soc. 2017;19(1–2):38–57. doi:10.1080/13698575.2017.1299856.
   Web of Science ®Google Scholar
• Haesebaert J, Lutringer-Magnin D, Kalecinski J, Barone G, Jacquard AC, Regnier V, Leocmach Y, Vanhems P, Chauvin F, Lasset C. French women’s knowledge of and attitudes towards cervical cancer prevention and the acceptability of HPV vaccination among those with 14-18 year old daughters: a quantitative-qualitative study. BMC Public Health. 2012;12(1). doi:10.1186/1471-2458-12-1034.
   PubMedGoogle Scholar
• Lutringer-Magnin D, Cropet C, Barone G, Canat G, Kalecinski J, Leocmach Y, Vanhems P, Chauvin F, Lasset C. HPV vaccination among French girls and women aged 14-23 years and the relationship with their mothers’ uptake of Pap smear screening: a study in general practice. Vaccine. 2013;31(45):5243–49. doi:10.1016/j.vaccine.2013.08.068.
   PubMed Web of Science ®Google Scholar
• Sabiani L, Bremond A, Mortier I, Lecuyer M, Boubli L, Carcopino X. HPV prophylactic vaccine coverage in France: results of a survey among high school and university students in marseilles’ area. J Gynecol Obstet Biol Reprod (Paris). 2012;41(2):136–44. doi:10.1016/j.jgyn.2011.10.001.
   PubMedGoogle Scholar
• Betsch C, Böhm R, Chapman GB. Using behavioral insights to increase vaccination policy effectiveness. Policy Insights Behav Brain Sci. 2015;2(1):61–73. doi:10.1177/2372732215600716.
   Google Scholar
• Slovic P, Peters E, Finucane ML, MacGregor DG. Affect, risk, and decision making. Health Psychol. 2005;24(4, Suppl):S35–S40. doi:10.1037/0278-6133.24.4.S35.
   PubMed Web of Science ®Google Scholar
• Epstein S. Integration of the cognitive and the psychodynamic unconscious. Am. Psychol 1994;49(8):709–24. doi:10.1037/0003-066X.49.8.709.
   PubMed Web of Science ®Google Scholar
• MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–64. doi:10.1016/j.vaccine.2015.04.036.
   PubMed Web of Science ®Google Scholar
• Reyna VF, Farley F. Risk and rationality in adolescent decision making: implications for theory, practice, and public policy. Psychol Sci Public Interest. 2006;7(1):1–44. doi:10.1111/j.1529-1006.2006.00026.x.
   PubMedGoogle Scholar
• Johnson RJ, McCaul KD, Klein WM. Risk involvement and risk perception among adolescents and young adults. J Behav Med. 2002;25(1):67–82. doi:10.1023/A:1013541802282.
   PubMed Web of Science ®Google Scholar
• Weinstein ND, Slovic P, Gibson G. Accuracy and optimism in smokers‘ beliefs about quitting. Nicotine Tob Res. 2004;6(Suppl 6):S375–380. doi:10.1080/14622200412331320789.
   PubMedGoogle Scholar
• Peretti‐Watel P, Ward JK, Vergelys C, Bocquier A, Raude J, Verger P. I think I made the right decision … I hope I’m not wrong’. Vaccine hesitancy, commitment and trust among parents of young children. Sociol Health Illn. 2019;41:1192–206.
   PubMed Web of Science ®Google Scholar
• Karafillakis E, Larson HJ. The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations. Vaccine. 2017;35(37):4840–50. doi:10.1016/j.vaccine.2017.07.061.
   PubMed Web of Science ®Google Scholar
• Rey D, Fressard L, Cortaredona S, Bocquier A, Gautier A, Peretti-Watel P, Verger P. group obotBs. Vaccine hesitancy in the French population in 2016, and its association with vaccine uptake and perceived vaccine risk–benefit balance. Eurosurveillance. 2018;23(17):17–00816. doi:10.2807/1560-7917.ES.2018.23.17.17-00816.
   Web of Science ®Google Scholar
• Dubé E, Gagnon D, MacDonald N, Bocquier A, Peretti-Watel P, Verger P. Underlying factors impacting vaccine hesitancy in high income countries: a review of qualitative studies. Expert Rev Vaccines. 2018;17(11):989–1004. doi:10.1080/14760584.2018.1541406.
   PubMed Web of Science ®Google Scholar
• Marti M, de Cola M, MacDonald NE, Dumolard L, Duclos P. Assessments of global drivers of vaccine hesitancy in 2014—Looking beyond safety concerns. Plos One. 2017;12(3):e0172310. doi:10.1371/journal.pone.0172310.
   PubMed Web of Science ®Google Scholar
• Huon J-F, Grégoire A, Meireles A, Lefebvre M, Péré M, Coutherut J, Biron C, Raffi F, Briend-Godet V. Evaluation of the acceptability in France of the vaccine against papillomavirus (HPV) among middle and high school students and their parents. Plos One. 2020;15(10):e0234693. doi:10.1371/journal.pone.0234693.
   PubMed Web of Science ®Google Scholar
• Mwale M. Adolescent risk-perception cognition and self-assessment in relation to the HIV/AIDS pandemic: the case of some selected schools in Zomba, Malawi. Psychol Dev Soc J. 2008;20(2):229–40. doi:10.1177/097133360802000205.
   Google Scholar
• Greening L, Stoppelbein L, Chandler CC, Elkin TD. Predictors of children’s and adolescents’ risk perception. J Pediatr Psychol. 2005;30(5):425–35. doi:10.1093/jpepsy/jsi066.
   PubMed Web of Science ®Google Scholar
• Gilkey MB, Grabert BK, Malo TL, Hall ME, Brewer NT. Physicians’ rhetorical strategies for motivating HPV vaccination. Soc Sci Med. 2020;266:113441. doi:10.1016/j.socscimed.2020.113441.
   PubMed Web of Science ®Google Scholar
• Marlow LAV, Wardle J, Waller J. Attitudes to HPV vaccination among ethnic minority mothers in the UK: an exploratory qualitative study. Hum Vaccin. 2009;5(2):105–10. doi:10.4161/hv.5.2.7368.
   PubMed Web of Science ®Google Scholar
• Marlow LAV, Waller J, Evans REC, Wardle J. Predictors of interest in HPV vaccination: a study of British adolescents. Vaccine. 2009;27(18):2483–88. doi:10.1016/j.vaccine.2009.02.057.
   PubMed Web of Science ®Google Scholar
• Bodson J, Wilson A, Warner EL, Kepka D, Grce M. Religion and HPV vaccine-related awareness, knowledge, and receipt among insured women aged 18-26 in Utah. Plos One. 2017;12(8):e0183725. doi:10.1371/journal.pone.0183725.
   PubMed Web of Science ®Google Scholar
• Salad J, Verdonk P, de Boer F, Abma TA. “A Somali girl is Muslim and does not have premarital sex. Is vaccination really necessary?” A qualitative study into the perceptions of Somali women in the Netherlands about the prevention of cervical cancer. Int J Equity Health. 2015;14(1):1–13. doi:10.1186/s12939-015-0198-3.
   PubMedGoogle Scholar
• Best AL, Thompson EL, Adamu AM, Logan R, Delva J, Thomas M, Cunningham E, Vamos C, Daley E. Examining the influence of religious and spiritual beliefs on HPV vaccine uptake among college women. J Relig Health. 2019;58(6):2196–207. doi:10.1007/s10943-019-00890-y.
   PubMed Web of Science ®Google Scholar
• Larson HJ, Schulz WS, Tucker JD, Smith DM. Measuring vaccine confidence: introducing a global vaccine confidence index. PLoS Curr. 2015;7.
   Google Scholar
• Lupton D. The social construction of medicine and the body. In: Handbook of social studies in health and medicine eds. Albrecht, Gary L., Fitzpatrick, Ray Fitzpatrick, and Scrimshaw, Susan C. (United Kingdom, London: SAGE Publications Ltd); 2000. p. 50–63.
   Google Scholar
• Bury MR. Social constructionism and the development of medical sociology. Sociol Health Illn. 1986;8(2):137–69. doi:10.1111/1467-9566.ep11340129.
   Web of Science ®Google Scholar
• Larson H, de Figueiredo A, Karafillakis E, and Rawal M. State of vaccine confidence in the EU. Vol. 2018, Luxembourg: European Union; 2018.
   Google Scholar
• Larson HJ, De Figueiredo A, Xiahong Z, Schulz WS, Verger P, Johnston IG, Cook AR, Jones NS. The state of vaccine confidence 2016: global insights through a 67-country survey. EBioMedicine. 2016;12:295–301. doi:10.1016/j.ebiom.2016.08.042.
   PubMed Web of Science ®Google Scholar
• Kahneman D, Tversky A. Prospect theory - analysis of decision under risk. Econometrica. 1979;47(2):263–91. doi:10.2307/1914185.
   Web of Science ®Google Scholar
• Weinstein ND, Kwitel A, McCaul KD, Magnan RE, Gerrard M, Gibbons FX. Risk perceptions: assessment and relationship to influenza vaccination. Health Psychol. 2007;26(2):146–51. doi:10.1037/0278-6133.26.2.146.
   PubMed Web of Science ®Google Scholar
• Vrinten C, McGregor LM, Heinrich M, von Wagner C, Waller J, Wardle J, Black GB. What do people fear about cancer? A systematic review and meta-synthesis of cancer fears in the general population. Psycho-Oncol. 2017;26(8):1070–79. doi:10.1002/pon.4287.
   PubMed Web of Science ®Google Scholar